Karen J Wilson's Net Worth
$13.1 Million
Who is Karen J Wilson?
Karen J Wilson has an estimated net worth of $13.1 Million. This is based on reported shares across multiple companies, which include JAZZ PHARMACEUTICALS INC, Vaxart, Inc., Elicio Therapeutics, Inc., PDL BIOPHARMA, INC., and VIROLOGIC INC.
SEC CIK
Karen J Wilson's CIK is 0001267490
Past Insider Trading and Trends
2014 was Karen J Wilson's most active year for acquiring shares with 10 total transactions. Karen J Wilson's most active month to acquire stocks was the month of February. 2014 was Karen J Wilson's most active year for disposing of shares, totalling 17 transactions. Karen J Wilson's most active month to dispose stocks was the month of February. 2012 saw Karen J Wilson paying a total of $1,015,827.78 for 105,292 shares, this is the most they've acquired in one year. In 2014 Karen J Wilson cashed out on 62,722 shares for a total of $5,518,676.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14
SVP, Finance & PAO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.05% | -578.00 |
$135.82 | -$78,503.96 | 18.39K |
Mar 5
| |||
Form 4
| +22.63% | 3.5K |
—
|
—
| 18.96K |
Feb 28
| |||
Form 4
| -3.37% | -540.00 |
$126.89 | -$68,522.30 | 15.46K |
Feb 25 - Feb 26
| |||
Form 4
| -19.27% | -3.76K |
$165.00 | -$620,400.27 | 15.76K |
Scheduled
|
May 11
| ||
Form 4
| -16.65% | -3.90K |
$155.00 | -$604,345.00 | 19.52K |
Scheduled
|
Apr 10
| ||
Form 4
| -1.27% | -302.00 |
$143.39 | -$43,303.78 | 23.42K |
Mar 5
| |||
Form 4
| +15.60% | 3.2K |
—
|
—
| 23.72K |
Mar 1
| |||
Form 4
| -4.03% | -861.00 |
$146.07 | -$125,766.48 | 20.52K |
Feb 26 - Feb 27
| |||
Form 4
| -5.69% | -1.27K |
$160.00 | -$204,000.00 | 21.13K |
Scheduled
|
Apr 27
| ||
Form 4
|
—
|
0
|
$102.09 | -$1,149,362.78 | 22.41K |
Scheduled
|
Apr 10
| ||
Form 4
| +15.95% | 3.08K |
$91.09 | $105,195.15 | 22.41K |
Mar 6 - Mar 8
| |||
Form 4
| +22.12% | 3.5K |
—
|
—
| 19.32K |
Mar 2
| |||
Form 4
| -5.58% | -935.00 |
$136.97 | -$128,066.95 | 15.82K |
Feb 27
| |||
Form 4
| -8.07% | -1.47K |
$150.01 | -$220,064.67 | 16.71K |
Aug 9
| |||
Form 4
| -3.24% | -604.00 |
$160.00 | -$96,640.00 | 18.06K |
Scheduled
|
Apr 25
| ||
Form 4
| -21.15% | -5.01K |
$150.00 | -$751,050.00 | 18.66K |
Scheduled
|
Apr 13
| ||
Form 4
| -8.37% | -2.16K |
$140.90 | -$304,484.90 | 23.67K |
Scheduled
|
Apr 7
| ||
Form 4
| -2.13% | -563.00 |
$127.84 | -$71,973.92 | 25.83K |
Mar 7
| |||
Form 4
| -1.30% | -348.00 |
$121.58 | -$42,309.84 | 26.39K |
Feb 29
| |||
Form 4
| +12.71% | 3.02K |
$125.00 | -$35,625.00 | 26.74K |
Feb 25 - Feb 26
| |||
Form 4
| -7.63% | -1.96K |
$181.48 | -$354,974.88 | 23.69K |
Aug 10
| |||
Form 4
| -0.99% | -257.00 |
$114.89 | -$757,073.98 | 25.64K |
Jun 1 - Jun 2
| |||
Form 4
| -2.15% | -563.00 |
$174.76 | -$98,389.88 | 25.64K |
Mar 5
| |||
Form 4
| +10.83% | 2.56K |
$102.15 | -$313,339.08 | 26.2K |
Mar 3 - Mar 4
| |||
Form 4
| +10.84% | 2.31K |
$170.09 | -$63,443.57 | 23.64K |
Feb 26 - Feb 27
| |||
Form 4
| -2.74% | -596.00 |
$110.23 | -$939,747.20 | 21.12K |
Nov 6
| |||
Form 4
|
—
|
0
|
$101.23 | -$442,620.00 | 21.71K |
Scheduled
|
Sep 11
| ||
Form 4
|
—
|
0
|
$98.73 | -$356,350.00 | 21.71K |
Scheduled
|
Sep 8
| ||
Form 4
| -8.26% | -1.96K |
$133.86 | -$261,830.16 | 21.71K |
Aug 11
| |||
Form 4
|
—
|
0
|
$96.23 | -$343,850.00 | 23.67K |
Scheduled
|
Jul 7
| ||
Form 4
| -3.65% | -888.00 |
$107.09 | -$425,405.52 | 23.41K |
Mar 7
| |||
Form 4
| -3.12% | -782.00 |
$157.60 | -$123,243.20 | 24.3K |
Mar 5
| |||
Form 4
| +17.58% | 3.75K |
$106.80 | -$1,349,312.50 | 25.08K |
Feb 27
| |||
Form 4
| -8.67% | -2.00K |
$87.62 | -$175,240.00 | 21.07K |
Aug 30
| |||
Form 4
| -5.75% | -1.41K |
$80.88 | -$113,959.92 | 23.07K |
Aug 9
| |||
Form 4
| +33.54% | 6K |
—
|
—
| 23.89K |
Mar 5
| |||
Form 4
| +654.45% | 15K |
—
|
—
| 17.29K |
Aug 9
| |||
Form 4
| -77.73% | -8.00K |
$49.56 | -$396,480.00 | 2.29K |
Mar 9
| |||
Form 4
|
∞
| 10.29K |
—
|
—
| 10.29K |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -10.29K |
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +4,896.12% | 10.09K |
$38.03 | -$291,852.42 | 10.29K |
Jan 11
| |||
Form 4
|
∞
| 206 |
$25.13 | $5,176.78 | 206 |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vaxart, Inc. (VXRT) Snapshot price: $0.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elicio Therapeutics, Inc. (ELTX) Snapshot price: $3.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
∞
| 18.72K |
$11.57 | $216,567.26 | 18.72K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
VP Finance & PAO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10.49K |
—
|
—
| 10.49K |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIROLOGIC INC No price found
Vice President, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
| No matching records found | |||||||||